Low Vitamin D levels linked to breast cancer survival rates.

vitamin dA new study from the University of San Diego has conclusively demonstrated that is correlated with survival rates. Professor Cedric Garland from the department of Family and Preventative Medicine indirectly examined 4,443 patients by performing a statistical analysis of five studies which followed the patients for nine years. The results refletc that women in the high serum group had an average level of 30 nanograms per milliliter (ng/ml) of 25-hydroxyvitamin D in their blood. The low group averaged 17 ng/ml which corresponds to the average level of patients in the . A prior analysis by Garland revealed that a serum level of 50 ng/ml is associated with 50 percent lower risk of .

increase communication between cells by switching on a protein that blocks aggressive cell division,” said Garland. “As long as receptors are present is prevented and kept from expanding its blood supply. receptors are not lost until a tumor is very advanced. This is the reason for better survival in patients whose blood levels are high.”

“The study has implications for including as an adjuvant to conventional therapy,” said co-author Heather Hofflich, DO, UC San Diego in the Department of Medicine.

The researchers recommend that physicians add to a patient’s average daily regiment.

“There is no compelling reason to wait for further studies to incorporate supplements into standard care regimens since a safe dose of needed to achieve high serum levels above 30 nanograms per milliliter has already been established,” said Garland.


Sharif B. Mohr, Edward D. Gorham, June Kim, Heather Hofflich And Cedric F. Garland. Meta-analysis of Sufficiency for Improving Survival of Patients with . Anticancer , March 2014

Be Sociable, Share!

    Leave a Reply

    Your email address will not be published. Required fields are marked *